Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
8 participants
INTERVENTIONAL
2023-05-15
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• which cooling protocol best prevents an increase in core temperature during exercise in the heat?
Participants will be asked to participate three times in a 60-minute exposure (to 40 degrees C, 40% relative humidity) in which they conduct three work/rest periods including 15 minutes of stepping exercise (20 steps/minute) and 5 minutes of rest. The following three conditions will include:
* Control: no cooling garments
* Upper-body cooling: cold water-perfused cooling vest
* Whole-body cooling: cold water-perfused cooling pants and cooling vest
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cooling Fabrics and Exercise Performance in Endurance Athletes
NCT02016521
Effect of Water Biking in Hot Versus Neutral Water for Heat Acclimatation
NCT05727774
Effect of Exercise and Heat Stress on Acute Cardiometabolic Adaptations in Healthy Young Adults
NCT06872762
The Burden of COVID-19 Survivorship
NCT04913129
Exercise Frequency During Endurance Training: Cardiorespiratory, Hematological, and Muscle Oxidative Adaptations
NCT05908578
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Physiologic measures:
Core temperature. Core temperature (°C) will be monitored with e-Celsius, an ingestible pill that continuously monitors, records, and wirelessly transmits core temperature.
Skin temperature. Mean skin temperature (ºC) will be measured with small metal discs (iButton, EDS) taped to the skin at the following 7 sites: forehead, chest, abdomen, upper arm, lower arm, anterior thigh, and anterior calf.
Heart rate and respiration. A Hexoskin shirt will be worn. Sensors in the shirt measure heart rate and chest expansion for breathing indicators.
Metabolism. Subjects will wear a face mask and oxygen consumption, VCO2 and minute ventilation is going to be continuously monitored with a metabolic cart.
Sweat loss. Will be determined from differences in body and clothing weight measured before and after the exercise trials.
Subjective measures:
Every 20 minutes during the exercise test (see below), participants will be asked to rate the following: thermal comfort, heat sensation, rating of perceived exertion (RPE), breathing comfort, and skin wetness.
This will be followed by a test of cognitive function. This involves two components: a three-item recall test and a clock-drawing task. Investigators will ask the subject to repeat three unrelated words (e.g., apple, table, penny) and then will ask them to recall those words after a few minutes. While the subject is trying to recall the words, investigators will ask them to draw a clock face including all of the numbers, and the hands showing a specific time (e.g., 10 minutes past 11). Then the subjects will then be asked to repeat the original 3 words in order.
Cooling procedures:
Cooling will be applied through a liquid-perfused shirt and pants. Each garment has small tubes sewn into the interior of the garment. Cold water (3-8 degrees C) will be perfused through the garments at 5 l/min. The garments will be worn over the Hexoskin shirt and shorts.
Exercise test:
This 60-minute test involves 3 sets of 15 minutes of stepping exercises (20 steps per minute) followed by 5 minutes of sitting rest. During the rest periods, They will be asked to give their subjective evaluations of thermal comfort, heat sensation, rating of perceived exertion, breathing comfort, skin wetness, and cognitive function.
The exercise test will be stopped and the subject will exit the chamber if: the core temperature reaches 39 degrees C; the subject feels light-headed, or nausea; the subject indicates a wish to stop for any reason; or a researcher feels the subject should stop for any reason.
Protocol:
Once subjects have been instrumented they will sit for 10 minutes of baseline measurements in the laboratory (\~20 degrees C). They will then enter a climatic chamber (40 degrees C, 40% humidity) and complete the 60-minute exercise/rest protocol. They will then exit the chamber and sit for another 10 minutes of post-exercise measurements.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Young healthy subjects
Young healthy subjects
Cold water-perfused cooling garment
Two types of cooling garments will be used. One is a cooling vest and the other includes cooling pants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cold water-perfused cooling garment
Two types of cooling garments will be used. One is a cooling vest and the other includes cooling pants.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meet the criteria on the CSEP Get Active Questionnaire
* Answer 'no' to questions in the Screening Questionnaire.
Exclusion Criteria
* Not meeting the criteria on the CSEP Get Active Questionnaire or the Screening Questionnaire.
18 Years
49 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manitoba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gordon Giesbrecht, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Manitoba
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
211 Max Bell Centre, University of Manitoba
Winnipeg, Manitoba, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HE2023-0101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.